The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014

Author： Trivers Katrina F. Rodriguez Juan L. Cox Summer L. Crane Barbara E. Duquette Debra

Publisher： MDPI

E-ISSN： 2227-9032|3|4|948-963

ISSN： 2227-9032

Source： Healthcare, Vol.3, Iss.4, 2015-10, pp. : 948-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome

By Trepanier Angela M. Supplee Laura Blakely Lindsey McLosky Jenna Duquette Debra

Healthcare, Vol. 4, Iss. 1, 2016-03 ,pp. : 19-19

MDPI

Access to resources Recommend Favorite

Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions

Chemotherapy, Vol. 62, Iss. 2, 2016-10 ,pp. : 111-120

Karger

Access to resources Recommend Favorite

A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis

By Longacre Mckenna Snyder Nicole A. Housman Genevieve Leary Meghan Lapinska Karolina Heerboth Sarah Willbanks Amber Sarkar Sibaji

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 759-759

MDPI

Access to resources Recommend Favorite

Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling

By Villegas Victoria E. Rondón-Lagos Milena Annaratone Laura Castellano Isabella Grismaldo Adriana Sapino Anna Zaphiropoulos Peter G.

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-02 ,pp. : 308-308

MDPI

Access to resources Recommend Favorite

The Important Molecular Markers on Chromosome 17 and Their Clinical Impact in Breast Cancer

By Zhang Wei Yu Yingyan

International Journal of Molecular Sciences, Vol. 12, Iss. 9, 2011-09 ,pp. : 5672-5683

MDPI

Access to resources Recommend Favorite